Insider · CIK 0001209181
James C Momtazee
director
Files at ROIV (Roivant Sciences Ltd.), BBIO (BridgeBio Pharma, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | ROIV Roivant Sciences Ltd. | AGrant or award Common Shares | +5,054 | $0.00 | $0 | 111,959 | 24 d ago |
| Sep 16, 2026 | ROIV Roivant Sciences Ltd. | AGrant or award Stock Option (Right to Buy)derivative | +10,531 | $0.00 | $0 | 10,531 | 24 d ago |
| Sep 10, 2026 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -2,905 | $40.94 | $119k | 106,905 | 28 d ago |
| Oct 20, 2025 | ROIV Roivant Sciences Ltd. | AGrant or award Common Shares | +789 | $0.00 | $0 | 108,701 | Oct 22, 2025 |
| Oct 20, 2025 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -158 | $17.74 | $2,803 | 108,543 | Oct 22, 2025 |
| Sep 10, 2025 | ROIV Roivant Sciences Ltd. | AGrant or award Common Shares | +14,524 | $0.00 | $0 | 111,194 | Sep 12, 2025 |
| Sep 10, 2025 | ROIV Roivant Sciences Ltd. | JOther Common Shares | -3,282 | $13.77 | $45k | 107,912 | Sep 12, 2025 |
| Sep 10, 2025 | ROIV Roivant Sciences Ltd. | AGrant or award Stock Option (Right to Buy)derivative | +33,726 | $0.00 | $0 | 33,726 | Sep 12, 2025 |
| Jul 17, 2025 | ROIV Roivant Sciences Ltd. | AGrant or award Common Shares | +1,201 | $0.00 | $0 | 96,911 | Jul 21, 2025 |
| Jul 17, 2025 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -241 | $11.65 | $2,808 | 96,670 | Jul 21, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Common Stock | +6,589 | $0.00 | $0 | 95,080 | Jun 24, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +8,425 | $0.00 | $0 | 8,425 | Jun 24, 2025 |
| Apr 17, 2025 | ROIV Roivant Sciences Ltd. | AGrant or award Common Shares | +1,379 | $0.00 | $0 | 95,986 | Apr 21, 2025 |
| Apr 17, 2025 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -276 | $10.15 | $2,801 | 95,710 | Apr 21, 2025 |
| Oct 21, 2024 | ROIV Roivant Sciences Ltd. | AGrant or award Common Shares | +1,231 | $0.00 | $0 | 93,665 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.